SafetyMargin.ioSafetyMargin.io
BlogWatchlistCompare
Compare Stocks › ABBV vs MDLZ

AbbVie Inc. (ABBV) vs Mondelez International, Inc. (MDLZ): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. MDLZ is overvalued at $60, with an intrinsic value of $35 and a margin of safety of -71%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
MDLZ
Mondelez International, Inc.
$60.12

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
MDLZ

    Risks

    ABBV
    • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
    • ⚠FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
    • ⚠Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
    MDLZ

      Key Valuation Metrics

      Learn more →
      ABBV
      MDLZ
      Valuation
      $20.81B
      Free Cash Flow
      $2.85B
      5.44%
      FCF Yield
      3.69%
      105.60
      Trailing P/E
      29.76
      13.32
      Forward P/E
      17.75
      Quality & Moat
      21.89%
      ROIC
      6.09%
      N/A
      ROE
      10.16%
      72.03%
      Gross Margin
      28.77%
      0.61
      PEG Ratio
      1.02
      Balance Sheet Safety
      N/A
      Net Debt / Equity
      0.78
      N/A
      Interest Coverage
      N/A
      2.12
      Net Debt / EBITDA
      3.85
      3.11%
      Dividend Yield
      3.22%
      ABBV: 7Ties: 2MDLZ: 1
      ABBVMDLZ

      Historical Fundamentals

      Learn more →
      ABBV

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      MDLZ

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

      $1 Retained Earnings Test

      Learn more →
      ABBV
      N/A
      Net losses over 3 years — test not applicable
      Company had negative cumulative retained earnings
      Σ Retained
      $-19.85B
      Δ Market Cap
      +$118.02B
      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
      MDLZ
      $-4.39
      created per $1 retained over 3 years
      Market Cap Declined
      Σ Retained
      $5.03B
      Δ Market Cap
      $-22.05B
      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

      Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
      > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

      Discounted Cash Flow (DCF) Analysis

      Learn more →
      ABBV
      35.3% Overvalued
      Price is 35.3% above estimated fair value
      Current Price: $216.49
      Fair Value: $160.05
      Strongly undervalued
      Undervalued
      Fairly valued
      Overvalued
      Strongly overvalued
      MDLZ
      71.1% Overvalued
      Price is 71.1% above estimated fair value
      Current Price: $60.12
      Fair Value: $35.15
      Strongly undervalued
      Undervalued
      Fairly valued
      Overvalued
      Strongly overvalued

      Reverse DCF — Market-Implied Growth

      Learn more →
      ABBV

      What growth rate is the market pricing in at $216?

      +17.1%
      Market-Implied Owner Earnings Growth
      Standard FCF implies +8.7%

      The market implies +17.1% Owner Earnings growth, above historical trends.

      Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

      MDLZ

      What growth rate is the market pricing in at $60?

      +16.6%
      Market-Implied Owner Earnings Growth
      Standard FCF implies +15.0%

      The market implies +16.6% Owner Earnings growth, above historical trends.

      Standard FCF implies a demanding +15.0%, reflecting heavy growth investment.

      Economic Moat Score

      Learn more →
      ABBV
      82/100
      Wide Moat
      70+ Wide · 40-69 Narrow · <40 None

      Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

      Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
      MDLZ
      48/100
      Narrow Moat
      70+ Wide · 40-69 Narrow · <40 None

      Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

      Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

      Forensic Accounting

      Learn more →
      ABBV
      -2.86
      Unlikely Manipulator
      Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

      M-Score Trend

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
      MDLZ
      -2.43
      Unlikely Manipulator
      Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

      M-Score Trend

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

      Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

      Ownership Breakdown

      Learn more →
      ABBV
      Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
      No. of Institutional Holders5,106
      High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
      MDLZ
      Insiders 0.2%Institutions 90.1%Retail & Other 9.6%
      No. of Institutional Holders2,492
      High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

      High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

      Insider Buying Activity

      Learn more →
      ABBV
      0
      Buys (3M)
      0
      Buys (12M)
      No open market insider purchases found.
      Open market purchases · includes direct & indirect ownership · excludes option exercises
      MDLZ
      0
      Buys (3M)
      0
      Buys (12M)
      No open market insider purchases found.
      Open market purchases · includes direct & indirect ownership · excludes option exercises

      Open market purchases · includes direct & indirect ownership · excludes option exercises.

      Insider Selling Activity

      Learn more →
      ABBV
      0
      Sells (3M)
      5
      Sells (12M)
      Total value (12M): $21.79M
      PURDUE DAVID R.
      Officer
      $1.22M
      @ $233.56 · 2026-03-04
      SIATIS PERRY C.
      General Counsel
      $4.38M
      @ $234.39 · 2026-03-02
      SIATIS PERRY C.
      General Counsel
      $5.15M
      @ $230.00 · 2026-02-25
      SALEKI-GERHARDT AZITA
      Chief Operating Officer
      $8.41M
      @ $198.42 · 2025-08-12
      DONOGHOE NICHOLAS
      Officer
      $2.64M
      @ $198.51 · 2025-08-05
      STEWART JEFFREY RYAN
      Officer
      $12.36M
      @ $210.08 · 2025-03-31
      REENTS SCOTT T.
      Chief Financial Officer
      $3.75M
      @ $212.34 · 2025-03-14
      GONZALEZ RICHARD A
      Director
      $20.26M
      @ $205.45 · 2025-03-03
      SIATIS PERRY C.
      General Counsel
      $5.82M
      @ $208.69 · 2025-03-03
      RICHMOND TIMOTHY J
      Officer
      $4.47M
      @ $210.45 · 2025-03-03
      BUCKBEE KEVIN K
      Officer
      $3.85M
      @ $203.41 · 2025-02-26
      RICHMOND TIMOTHY J
      Officer
      $6.07M
      @ $202.90 · 2025-02-26
      SIATIS PERRY C.
      General Counsel
      $1.14M
      @ $197.90 · 2025-02-20
      BUCKBEE KEVIN K
      Officer
      $310,032
      @ $172.24 · 2024-12-16
      GONZALEZ RICHARD A
      Officer and Director
      $12.40M
      @ $186.52 · 2024-08-05
      GONZALEZ RICHARD A
      Officer and Director
      $49.50M
      @ $175.00 · 2024-07-17
      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
      MDLZ
      0
      Sells (3M)
      1
      Sells (12M)
      Total value (12M): $186,000
      VALLE GUSTAVO CARLOS
      Officer
      $186,000
      @ $62.00 · 2026-02-13
      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

      Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

      🎭 Mr. Market's Mood

      Learn more →
      ABBV
      FearGreed
      😐Neutral(56/100)

      "Market is pricing this stock without strong emotion in either direction"

      Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
      MDLZ
      FearGreed
      😐Neutral(47/100)

      "Market is pricing this stock without strong emotion in either direction"

      Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

      Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

      ⚖️ Buffett Signal

      Learn more →
      ABBV
      ⚪Awaiting DCF Data

      The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

      DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
      MDLZ
      ⚪Awaiting DCF Data

      The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

      DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)
      View ABBV Full AnalysisView MDLZ Full Analysis

      Frequently Asked Questions: ABBV vs MDLZ

      Is AbbVie Inc. or Mondelez International, Inc. more undervalued in 2026?▼

      Based on our discounted cash flow model, ABBV trades at a -35.3% margin of safety (intrinsic value $160 vs. price $216), compared to MDLZ's -71.1% margin of safety (intrinsic $35 vs. $60).

      Which stock has a wider economic moat, AbbVie Inc. or Mondelez International, Inc.?▼

      ABBV scores 82/100 (Wide moat), while MDLZ scores 48/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

      Is Mondelez International, Inc. in financial distress?▼

      MDLZ's Altman Z-Score of 2.2 places it in the Grey zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

      Which company has better free cash flow, AbbVie Inc. or Mondelez International, Inc.?▼

      AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to Mondelez International, Inc.'s 3.7%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

      Which stock has higher return on invested capital, AbbVie Inc. or Mondelez International, Inc.?▼

      ABBV earns 21.9% ROIC versus MDLZ's 6.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

      Which dividend is safer, AbbVie Inc.'s or Mondelez International, Inc.'s?▼

      MDLZ's dividend earns a safety score of 39/100 (Unsafe), compared to ABBV's 39/100 (Unsafe). MDLZ has raised its dividend for 3 consecutive years.